Australian Medical Association

AMA Position Statement on Doctors’ Relationships With Industry 2010

The AMA today released a revised Position Statement to provide guidance to doctors on maintaining ethical relationships with the pharmaceutical industry, the medical device and technology industry, and other care and product suppliers.

The Position Statement on Doctors’ Relationships with Industry 2010 sets out major principles for doctors’ relationships with industry, including managing potential conflicts of interest.

AMA President, Dr Andrew Pesce, said the AMA believes that collaboration between doctors and industry contributes beneficially to the quality of health care that Australians receive.

“However, doctors have a responsibility to ensure that their relationships with industry are consistent with their duties to their patients and to society at large,” Dr Pesce said.

MJA Media Release -  Buprenorphine-naloxone a helpful addition to opioid substitution treatment

People who inject drugs may be less likely to inject buprenorphine-naloxone than other opioid substitutes, according to the results of a recent study published in the Medical Journal of Australia.

Buprenorphine is used to treat heroin dependence.

AMA Position Statement: Medicines - 2008

AMA Position Statement: Pharmacy Intranet Scheme - 1997

AMA Position Statement: Drugs in Sport - 2000

AMA Position Statement: Use And Misuse Of Medicines And Drugs - 1998